Pyschotic Disorders
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study (NCT00645320) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-08-01 |
Track Pyschotic Disorders automatically
Every clearance here is in the API, with alerts when new ones post.